Occipital versus Non-Occipital Migraine Pain: Clinical Characteristics, Differential Diagnosis, Treatment Response, Anatomical, and Pathophysiological Perspectives
DOI:
https://doi.org/10.46531/sinapse/AO/157/2025Keywords:
Migraine Disorders/diagnosis, Migraine Disorders/prevention and control, Migraine Disorders/therapyAbstract
Introduction: In this study, we aimed to compare clinical characteristics and treatment responses in patients with migraine with occipital pain and those with non-occipital pain. We hypothesized that the area of pain could influence clinical features and treatment responses.Methods: We conducted a retrospective review of patients diagnosed with episodic or chronic migraine who attended a Neurology (Headache) outpatient clinic between January 2022 and December 2024. Patients were divided into two groups: Group 1 (People with migraine with occipital pain) and Group 2 (People with migraine with non-occipital pain). Data were collected on demographic characteristics, clinical features, and treatment responses.
Results: A total of 100 patients were enrolled, with 50 included in Group 1 [39 patients (78%) with episodic migraine; 40 (80%) females], and 50 patients included in Group 2 [40 patients (80%) with episodic migraine; 43 (86%) females]. No significant difference was found in gender distribution (p=0.603), age of migraine onset (p=0.904), or time until diagnosis (p=0.205). Group 1 had more frequent bilateral pain (50% vs 38%, p=0.003) and a higher mean of migraine days per month (11 vs 6, p=0.004). Similar proportions of patients started oral preventive treatment (70% vs 80%, p=0.248). In Group 1, the most prescribed drug was amitriptyline, while in Group 2, it was topiramate. Group 1 had higher treatment failure rates than Group 2 (70% vs 31%, p<0.001). After adjusting for monthly migraine frequency, occipital pain remained independently associated with a poorer response to preventive treatment (adjusted OR = 0.33; 95% CI: 0.14–0.77; p=0.01).
Conclusion: Patients with occipital migraine experience more bilateral pain, migraine frequency, and higher treatment failure rates. These findings suggest the need for tailored treatment strategies based on migraine pain localization.
Downloads
References
Noseda R, Melo-Carrillo A, Nir RR, Strassman AM, Burstein R. Non-Trigeminal Nociceptive Innovation of the Posterior Dura: Implications to Occipital Headache. J Neurosci. 2019;39(1867-80). 10.1523/JNEUROSCI.2153-18.2018.
Sjaastad O, Fredriksen T, Sand T. The localization of the initial pain of attack: A comparison between classic migraine and cervicogenic headache. Funct Neurol. 1989;4:73-8.
Sjaastad O, Bovim G, Stovner LJ. Common migraine (“migraine without aura”): Localization of the initial pain of attack. Funct Neurol. 1993;8:27-32.
Barmherzig R, Kingston W. Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management. Curr Neurol Neurosci Rep. 2019;19:20. doi: 10.1007/s11910-019-0937-8.
Kelman L. Migraine Pain Location: A Tertiary Care Study of 1283 Migraineurs. Headache 2005;45:1038-47. doi: 10.1111/j.1526-4610.2005.05185.x.
Baldelli I, Mangiaiaroli ML, Salgarello M, Raposio E. Peripheral Occipital Nerve Decompression Surgery in Migraine Headache. Plast Reconstr Surg Glob Open. 2020;8:e3019. 10.1097/GOX.000000000003019.
Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18:805-35. doi: 10.1097/EDE.0b013e3181577511.
Love SM, Hopkins BD, Migdal CW, Schuster NM. Occipital Headache Evaluation and Rates of Migraine Assessment, Diagnosis, and Treatment in Patients Receiving Greater Occipital Nerve Blocks in an Academic Pain Clinic. Pain Med. 2022;23:1851-7. 10.1093/pm/pmac080.
Marshall A, Lindsay R, Clementi MA, Gelfand AA, Orr SL. Outpatient Approach to Resistant and Refractory Migraine in Children and Adolescents: a Narrative Review. Curr Neurol Neurosci Rep. 2022;22:611-24. 10.1007/s11910-022-01224-4.
Wattiez AS, O’Shea SA, Ten Fyck P, Sowers LP, Recober A, Russo AF, et al. Patient With Vestibular Migraine are More likely to Have Occipital Headaches than those With Migraine Without Vestibular Symptoms. Headache 2020;60:1581-91. 10.1111/head.13898.
Maxey BS, Pruitt JW, Deville A, Montgomery C, Kaye AD, Urtis I. Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine. Curr Pain Headache Rep. 2022;26:337-46. doi: 10.1007/s11916-022-01026-w.
Cevik U, Arslan D. Similarities and differences between migraine and other types of headaches: Migraine mimics. Neurol Perspect. 2023;3:100122. 10.1016/j.neurop.2023.100122.
Bond KM, Benson JC, Cutsforth-Gregory JK, Kim DK, Diehn FE, Carr CM. Spontaneous Intracranial Hypotension: Atypical Radiologic Appearances, Imaging Mimickers, and Clinical Look-Alikes. AJNR Am J Neuroradiol. 2020;41:1339-47. 10.3174/ajnr.A6637.
Erdener SE, Kaya Z, Dalkara T. Parenchymal neuroinflammatory signalling and dual neurogenic inflammation in migraine. J Headache Pain. 2021;22:138. 10.1186/s10194-021-01353-0.
Karasn N. Pathophysiology of Migraine. Continuum. 2024;30:325-43. 10.1212/CON.00000000000001412.
Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep. 2003;7:377-83. 10.1007/s11916-003-0037-x.
Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol. 2013;74:145-8. 10.1002/ana.23869.
Zhang H, Yang X, Lin Y, Chen L, Ye H. The efficacy of greater occipital nerve block for the treatment of migraine: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2018;165:1291-133. 10.1016/j.clinneuro.2017.12.026.
Silberstein SD, Holland S, Freiberg F, Dodick DW, Argoff C, Ashman E, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337-45. doi: 10.1212/WNL.0b013e3182535620.
Lipton RB, Munjal S, Buse DC, Fanning KM, Bennett A, Reed ML. Predicting inadequate response to acute migraine medication: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2016;56:1635-48. doi: 10.1111/head.12941.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gonçalo Cabral, Carolina Gonçalves, Miguel Serôdio, Rita Pelejão
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
